Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study

This postmarketing surveillance study was conducted to evaluate the safety and effectiveness of onabotulinumtoxinA in Japanese patients with laryngeal dystonia (LD). Patients receiving onabotulinumtoxinA for the first time were enrolled and observed for up to 12 months following the first injection....

Descripción completa

Detalles Bibliográficos
Autores principales: Iimura, Shigeomi, Nose, Yasuyo, Tabata, Keiko, Oda, Kenji, Yamashita, Yoshiyuki, Takahashi, Naohiro, Kawano, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537561/
https://www.ncbi.nlm.nih.gov/pubmed/37755979
http://dx.doi.org/10.3390/toxins15090553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537561/
https://www.ncbi.nlm.nih.gov/pubmed/37755979
http://dx.doi.org/10.3390/toxins15090553

Ejemplares similares